Who owns TAYSHA GENE THERAPIES INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Taysha Gene Therapies with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Taysha Gene Therapies stock

Who bought or sold TAYSHA GENE THERAPIES INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
FMR 5.7M $121M 0% Jun 2021
BlackRock 3.0M $63M 31% Jun 2021
University of Texas Investment Management Company 1.4M $30M -36% Jun 2021
Franklin Resources 1.3M $28M 17% Jun 2021
Artal Group 1.0M $22M 0% Jun 2021
Sands Capital Management 725k $15M 0% Jun 2021
TimesSquare Capital Management 683k $15M 72% Jun 2021
Vanguard Group 629k $13M 37% Jun 2021
Tybourne Capital Management 500k $11M 0% Jun 2021
Nantahala Capital Management 432k $9.2M 1069% Jun 2021
Perceptive Advisors 320k $6.8M -32% Jun 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Taysha Gene Therapies?

Octagon Capital Advisors 320k $6.8M 0% Jun 2021
State Street Corporation 319k $6.8M 161% Jun 2021
Geode Capital Management 263k $5.6M 73% Jun 2021
Northern Trust 199k $4.2M 105% Jun 2021
Charles Schwab Investment Management 87k $1.8M 49% Jun 2021
Nuveen Asset Management 80k $1.7M 357% Jun 2021
Bank of New York Mellon 57k $1.2M 110% Jun 2021
Granite Point Capital Management 50k $1.1M 100% Jun 2021
Gilder, Gagnon, Howe & Co 38k $798k 0% Jun 2021
Swiss National Bank 38k $795k 100% Jun 2021
Morgan Stanley 36k $0 100% Jun 2021
Pura Vida Investments 34k $717k 100% Jun 2021
California State Teachers Retirement System 31k $651k 134% Jun 2021
Millennium Management 30k $639k 43% Jun 2021
State of Wisconsin Investment Board 29k $611k 100% Jun 2021
Jpmorgan Chase & Co 26k $532k 10% Mar 2021
Bank of America Corporation 24k $517k 64% Jun 2021
New York State Common Retirement Fund 19k $406k 118% Jun 2021
Rhumbline Advisers 19k $396k 100% Jun 2021
Davenport & Co 14k $292k -32% Jun 2021
Deutsche Bank Aktiengesellschaft 14k $265k 131% Jun 2021
Credit Suisse 13k $283k 100% Jun 2021
Manufacturers Life Insurance Company 13k $275k 100% Jun 2021
American International 13k $264k 147% Jun 2021
D. E. Shaw & Co 11k $243k 100% Jun 2021
MetLife Investment Advisors 9.5k $202k 100% Jun 2021
Virtus ETF Advisers 8.7k $184k 100% Jun 2021
Metropolitan Life Insurance Company 7.3k $154k 100% Jun 2021
UBS Group 5.3k $112k -85% Jun 2021
Legal & General Group 3.7k $80k 310% Jun 2021
Summit Investment Advisors 1.7k $37k 140% Jun 2021
Royal Bank of Canada 1.5k $0 75% Jun 2021
Captrust Financial Advisors 1.0k $22k 6% Jun 2021
Tower Research Capital 976.00 $22k 56% Jun 2021
Citigroup 576.00 $12k -64% Mar 2021
Advisor Group Holdings 241.00 $5.0k 0% Jun 2021

Who sold out of Taysha Gene Therapies?

Fund or Company Name Date Sold Shares Held Valued At
Casdin Capital Mar 2021 820k $17M
VR Adviser Mar 2021 121k $2.4M
Arrowpoint Asset Management Mar 2021 116k $2.3M
Wells Fargo & Company Mar 2021 57k $1.2M
Alyeska Investment Group Mar 2021 25k $508k
Goldman Sachs Group Dec 2020 15k $392k
Hrt Financial Mar 2021 12k $248k
OTR - Nominee Name for The State Teachers Retirement Board of Ohio Mar 2021 2.1k $42k
Bank Of Montreal Mar 2021 268.00 $5.0k